PATENT CLAIM ANALYSIS

Application Number: 15885630
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "047000"]

Abstract:
A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.

Claim (Index 51):
The method of  claim 50 , wherein the additional anti-HCV agent is selected from the group consisting of a protease inhibitor, an NS5A inhibitor, another NS5B polymerase inhibitor, a non-substrate inhibitor, interferon alfa-2a, ribavirin, a helicase inhibitor, an antisense oligodeoxynucleotide, an aptamer, a nuclease-resistant ribozyme, iRNA, an antibody to HCV, a partial antibody to HCV, and a domain antibody to HCV.

Metadata:
- Claim Count in Document: 131.0
- Percentile: 86.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14252290', '15782628', '10607909', '11516928', '15744094']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7881470755178718
- 35 USC 102 Novelty (BERT): 0.5026261980228967
- Combined Prediction Score: 0.7595949877683742
- Mean Citation Score: 250.91714399999995
- Max Citation Score: 261.86374
- Similarity Product: 203.2259346855402

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test